跳至主要内容
临床试验/EUCTR2019-003771-19-DK
EUCTR2019-003771-19-DK进行中(未招募)1 期

The effect of improved insulin sensitivity on bone turnover markers and bone biomechanical properties in persons with type 2 diabetes mellitus - METCERCISE

Aarhus Universitetshospital0 个研究点目标入组 104 人开始时间: 2019年10月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Diagnosed type 2 diabetes mellitus
  • Alder = 45 years
  • Male gender OR female gender and postmenopausality
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 52
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 52

排除标准

  • Current or previous treatment with other antidiabetics than metformin
  • Premature menopause (menopause before 40 years of age)
  • Treatment with systemic glucocorticoids within 2 years
  • Treatment with antiresorptive or bone anabolic drugs (ever)
  • Lithium treatment (ever)
  • Anticonvulsive treatment (ever)
  • Current menopausal hormone replacement therapy
  • eGFR < 60 ml/min
  • Significant cardiovascular, endocrinological, renal, hepati, rheumatological, gastrointestinal or other illness
  • Osteoporosis or other bone disease
  • D-vitamine deficiency
  • Recent bone fractures (6 months)
  • Previous fractures in both ankles (tibia) or both wrists (radius)
  • Active cancer within previous 5 years or other unstable medical illness
  • Assessed inability to participate in trial-related interventions or examinations
  • Allergy to relevant pharmaceuticals

研究者

发起方
Aarhus Universitetshospital

相似试验